3D and 4D-QSAR of Dopamine Transporter Inhibitors (DAT) using the LQTA-QSAR approach (2019)
Source: Proceedings. Conference titles: Molecules Medicinal Chemistry Symposium - MMCS. Unidade: FFCLRP
Subjects: DROGAS DE ABUSO, NEUROTRANSMISSORES, SAÚDE PÚBLICA, FARMACOTERAPIA
ABNT
MELO, Eduardo Borges de e BRUNI, Aline Thaís e MARTINS, João Paulo Ataide. 3D and 4D-QSAR of Dopamine Transporter Inhibitors (DAT) using the LQTA-QSAR approach. Proceedings. Basel: MDPI AG. Disponível em: https://doi.org/10.3390/proceedings2019022112. Acesso em: 01 nov. 2024. , 2019APA
Melo, E. B. de, Bruni, A. T., & Martins, J. P. A. (2019). 3D and 4D-QSAR of Dopamine Transporter Inhibitors (DAT) using the LQTA-QSAR approach. Proceedings. Basel: MDPI AG. doi:10.3390/proceedings2019022112NLM
Melo EB de, Bruni AT, Martins JPA. 3D and 4D-QSAR of Dopamine Transporter Inhibitors (DAT) using the LQTA-QSAR approach [Internet]. Proceedings. 2019 ; 22( 1): 1.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/proceedings2019022112Vancouver
Melo EB de, Bruni AT, Martins JPA. 3D and 4D-QSAR of Dopamine Transporter Inhibitors (DAT) using the LQTA-QSAR approach [Internet]. Proceedings. 2019 ; 22( 1): 1.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/proceedings2019022112